IMR Press / CEOG / Volume 41 / Issue 5 / DOI: 10.12891/ceog17342014

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Case Report
A case of uterine rupture in mid-trimester spontaneous abortion: a complication of gemeprost vaginal administration
Show Less
1 Department of Obstetrics, Gynaecology and Urologic Sciences,” Sapienza” University, Rome (Italy)
Clin. Exp. Obstet. Gynecol. 2014, 41(5), 599–600; https://doi.org/10.12891/ceog17342014
Published: 10 October 2014
Abstract

The only prostaglandin analogue licensed in Italy for induction of labour in spontaneous and therapeutic abortion is gemeprost. The authors report a case of spontaneous uterine rupture of a scarred uterus, for previous caesarean sections, in a woman at 20 weeks of gestation with a diagnosis of spontaneous abortion. She received a pessary of gemeprost every three hours. After the fifth pessary, she complained of severe pain. At the ultrasound examination, uterine cavity appeared empty and the dead fetus was dislocated in the abdomen. Emergency laparotomy was performed and uterine tear was repaired. To induce labour for fetal demise or therapeutic abortion in second trimester in women with scarred uterus, the authors decided to lengthen the time between administrations of pessary from four to five hours depending on patient’s symptoms. However the appropriate drug regimen has still to be found and more data are necessary.
Keywords
Gemeprost
Spontaneous abortion
Uterine rupture
Share
Back to top